Clinical Trial

Pinoxin for the Prevention of Radiation-Induced Skin Injury

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 22, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The incidence of radiation-induced skin injury is high, and effective preventive measures are currently lacking. This study evaluates the role of the skin protective agent Pinoxin in preventing skin injury. Patients are randomly assigned into two prospective groups: treatment group and control group. In treatment group, patients will receive Pinoxin treatment. In control group，patients will receive placebo treatment. The rate of grade 2 or greater skin injury will be analyzed.
Trial Details
NCT Number NCT07545720
Lead Sponsor Fudan University
Conditions Cancer Patients Undergoning Radiotherapy
Enrollment 202 participants
Start Date 2024-09-05
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-22